SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001013594-24-000193
Filing Date
2024-02-14
Accepted
2024-02-14 16:16:39
Documents
1

Document Format Files

Seq Description Document Type Size
1 durect13ga3-02142024.htm SC 13G/A 152934
  Complete submission text file 0001013594-24-000193.txt   154471
Mailing Address 10240 BUBB ROAD CUPERTINO CA 95014
Business Address 10240 BUBB ROAD CUPERTINO CA 95014 4087771417
DURECT CORP (Subject) CIK: 0001082038 (see all company filings)

IRS No.: 943297098 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-60499 | Film No.: 24638512
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 250 WEST 55TH STREET 33RD FLOOR NEW YORK NY 10019
Business Address 250 WEST 55TH STREET 33RD FLOOR NEW YORK NY 10019 212-356-6200
Lion Point Capital, LP (Filed by) CIK: 0001643354 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1230
Type: SC 13G/A